Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Inclusion Criteria

• •Subject is \> 18 years of age
• •Clinical and radiological diagnosis of metastatic cancer with histological verification.
• •White blood cell count: \> 2.0 x 10\^9/L
• •Haemoglobin: \> 80 g/L
• •Platelets: \> 50.0 x 10\^9/L
• •Bilirubin =\< 2.0 times Upper Limit of Normal
• •Serum creatinine: Within Normal Limits
• •Blood glucose level not more than 5.9 mmol/L
• •A negative pregnancy test (serum beta-human chorionic gonadotropin, beta-HCG) at screening for all patients of childbearing potential. Sexually active women of childbearing potential participating in the study must use a medically acceptable form of contraception for at least 30 days after study termination
• •Subject is capable to undergo the diagnostic investigations to be performed in the study
• •Informed consent